Siena, the Italian city of the Palio, is increasingly establishing itself as the beating heart of national Life Sciences. At the center of the debate is the integration of Artificial Intelligence (AI), biotechnology, and youth training, which are the key pillars to ensuring the “scientific sovereignty” the country needs to compete on a global scale.
This was the core message emerging from a strategic meeting between the Biotecnopolo of Siena Foundation and the SAI Hub Foundation (Siena Artificial Intelligence Hub). The event, intended to bridging research, education, and industry, featured top leadership from both institutions, including the CEO of Biotecnopolo, Gianluca Polifrone, the Vice President Annalisa Santucci, the SAI Hub President Stefano Chiellini, and Claudio Balestri.
The stated goal is clear: to build an integrated supply chain that guides talent from university halls to applied research and the industrial world. In an era where biology is increasingly merged with data analysis, AI is no longer just a support tool but a strategic lever capable of redefining biomedical research models.
According to the CEO Gianluca Polifrone, investing in new generations is a structural necessity: “There is no health sovereignty without scientific sovereignty. This is built by investing in public research, skills, and the ability to transform talent into innovation.” The fundamental idea behind Biotecnopolo is to provide an excellent public infrastructure capable of retaining top minds in Italy, enabling them to compete at the highest international levels.
The role of SAI Hub is emerging as fundamental within this ecosystem. Established as a technological hub for AI development, the center represents the innovative arm that accelerates research processes, reduces drug development timelines, and enhances the analysis of complex biological systems. The integration of SAI Hub’s computational expertise with Biotecnopolo’s biological research aims to create a unique ecosystem. As highlighted during the meeting, the collaboration between these local entities, which has a strong international outlook, is a necessary condition for consolidating Italy’s position in the global Life Sciences landscape.
The debate also touched upon themes that are attracting the interest of the local and national scientific community. In addition to institutional speeches, the visions of experts such as Dario Neri (CEO of Philogen) were cited, who recently reiterated the importance of teamwork in the biomedical sector. World-renowned scientist Rino Rappuoli also weighed in, identifying the union of AI and young researchers as the key to overcoming future health challenges, starting with pandemic preparedness.
It can be assumed that Siena is officially positioning itself as an open-air laboratory where the future of Italian research is being written. The challenge is set: to transform knowledge into concrete development, economic competitiveness, and safety for all citizens.
